Ph.D. Psychology, University of Kentucky
M.A. Psychology, Unidersity of Kentucky
B.A. Psychology, Davidson College
Dr. Stoops was promoted to the rank of Professor in 2017. He continued work as principal investigator on two NIDA-funded grants (R01 DA 036553 and R21 DA 035376) and began two new NIH funded projects as principal investigator. The first, R01 DA 043938, will determine how reductions in cocaine use change cardiovascular, immune and psychosocial health. The second, R21 AA 026129, represents Dr. Stoops’ first project funded by NIAAA and will determine the influence of n-acetylcysteine on the reinforcing, subjective and physiological effects of alcohol. Dr. Stoops served as a co-Investigator or consultant on over ten other NIH-funded grants, including the University of Kentucky Center for Clinical and Translational Science (CCTS). He published eight peer-reviewed manuscripts, five as senior author, in 2017. He presented his research at the College on Problems of Drug Dependence and the American Psychological Association and gave invited addresses at the Medical University of South Carolina Department of Psychiatry Grand Rounds, the Temple University Center for Substance Abuse Research Seminar and the Office of Human Research Protection Community Research Forum. Dr. Stoops continued his leadership roles as Director of the Regulatory Knowledge and Support Core and Component Lead for Research Methods of the UK CCTS. Dr. Stoops contributed to the teaching mission of the University of Kentucky in 2017 by serving as the primary mentor to one graduate student. He co-mentored two post-doctoral fellows and one graduate student. He also was course director for BSC 534 (Ethics and Responsibility in Clinical Research) for the Spring 2017 semester. Dr. Stoops maintained his strong commitment to service to the field at a national level in 2017, including 1) chairing the Board of Convention Affairs of the American Psychological Association, 2) serving as Program Chair of the College on Problems of Drug Dependence, 3) serving on the Board of Directors of the College on Problems of Drug Dependence, 4) serving on the Interventions to Prevent and Treat Addiction NIH study section, 5) editing a special issue on decision making in addiction for Pharmacology, Biochemistry and Behavior and 6) serving as incoming editor of Experimental and Clinical Psychopharmacology. He was also elected to serve as Council Representative for American Psychological Association Division 28 (Psychopharmacology and Substance Abuse), beginning in 2018.
A Human Laboratory Study of n-Acetylcysteine for Alcohol Use Disorder (R21AA026129). National Institute on Alcohol Abuse and Alcoholism.
Selective Monoamine Release as a Treatment for Cocaine Use Disorders (R01DA036553). National Institute on Drug Abuse.
Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use (R01DA043938). National Institute on Drug Abuse.
Motivation for Cocaine and Non-Drug Reinforcers: Targeting Glutamate Homeostasis (R21DA035376). National Institute on Drug Abuse.
Stoops, W.W., Strickland, J.C., Hays, L.R., Rayapati, A.O., Lile, J.A. and Rush, C.R. (2016). Safety and Tolerability of Intranasal Cocaine During Phendimetrazine Maintenance. Psychopharmacology, 233, 2055-2063.
Strickland, J.C., Bolin, B.L., Lile, J.A., Rush, C.R. and Stoops, W.W. (2016). Differential Sensitivity in Learning from Positive and Negative Outcomes in Cocaine Users. Drug and Alcohol Dependence, 166, 61-68.
Bolin, B.L., Alcorn III, J.L., Lile, J.A., Rush, C.R., Rayapati, A.O., Hays, L.R. and Stoops, W.W. (2017). n-Acetylcysteine Reduces Cocaine-Cue Attentional Bias and Differentially Alters Cocaine Self-Administration Based on Dosing Order. Drug and Alcohol Dependence, 178, 452-460.
Strickland, J.C., Beckmann, J.S., Rush, C.R. and Stoops, W.W. (2017). A Pilot Study of Loss Aversion for Drug and Non-Drug Commodities in Cocaine Users. Drug and Alcohol Dependence, 180, 223-226.